ID   FFAR2_RAT               Reviewed;         330 AA.
AC   Q76EI6;
DT   21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   29-MAY-2024, entry version 122.
DE   RecName: Full=Free fatty acid receptor 2;
DE   AltName: Full=G-protein coupled receptor 43;
GN   Name=Ffar2; Synonyms=Gpr43;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Tanaka H., Shinohara T., Ogi K., Hosoya M., Fukusumi S., Noguchi Y.,
RA   Tanaka Y., Kizawa H., Fujii R., Itoh Y., Hinuma S., Fujisawa F., Fujino M.;
RT   "Search for ligands of GPR43 and analysis for its mRNA expression.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=16453106; DOI=10.1007/s00441-005-0140-x;
RA   Karaki S., Mitsui R., Hayashi H., Kato I., Sugiya H., Iwanaga T.,
RA   Furness J.B., Kuwahara A.;
RT   "Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine
RT   cells and mucosal mast cells in rat intestine.";
RL   Cell Tissue Res. 324:353-360(2006).
RN   [3]
RP   FUNCTION.
RX   PubMed=23589301; DOI=10.1074/jbc.m113.455337;
RA   Hudson B.D., Due-Hansen M.E., Christiansen E., Hansen A.M., Mackenzie A.E.,
RA   Murdoch H., Pandey S.K., Ward R.J., Marquez R., Tikhonova I.G., Ulven T.,
RA   Milligan G.;
RT   "Defining the molecular basis for the first potent and selective
RT   orthosteric agonists of the FFA2 free fatty acid receptor.";
RL   J. Biol. Chem. 288:17296-17312(2013).
CC   -!- FUNCTION: G protein-coupled receptor that is activated by a major
CC       product of dietary fiber digestion, the short chain fatty acids
CC       (SCFAs), and that plays a role in the regulation of whole-body energy
CC       homeostasis and in intestinal immunity. In omnivorous mammals, the
CC       short chain fatty acids acetate, propionate and butyrate are produced
CC       primarily by the gut microbiome that metabolizes dietary fibers. SCFAs
CC       serve as a source of energy but also act as signaling molecules. That G
CC       protein-coupled receptor is probably coupled to the pertussis toxin-
CC       sensitive, G(i/o)-alpha family of G proteins but also to the Gq family
CC       (PubMed:23589301). Its activation results in the formation of inositol
CC       1,4,5-trisphosphate, the mobilization of intracellular calcium, the
CC       phosphorylation of the MAPK3/ERK1 and MAPK1/ERK2 kinases and the
CC       inhibition of intracellular cAMP accumulation. May play a role in
CC       glucose homeostasis by regulating the secretion of GLP-1, in response
CC       to short-chain fatty acids accumulating in the intestine. May also
CC       regulate the production of LEP/Leptin, a hormone acting on the central
CC       nervous system to inhibit food intake. Finally, may also regulate
CC       whole-body energy homeostasis through adipogenesis regulating both
CC       differentiation and lipid storage of adipocytes. In parallel to its
CC       role in energy homeostasis, may also mediate the activation of the
CC       inflammatory and immune responses by SCFA in the intestine, regulating
CC       the rapid production of chemokines and cytokines. May also play a role
CC       in the resolution of the inflammatory response and control chemotaxis
CC       in neutrophils. In addition to SCFAs, may also be activated by the
CC       extracellular lectin FCN1 in a process leading to activation of
CC       monocytes and inducing the secretion of interleukin-8/IL-8 in response
CC       to the presence of microbes. {ECO:0000269|PubMed:23589301}.
CC   -!- SUBUNIT: Interacts with FCN1 (via Fibrinogen C-terminal domain).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Detected in whole wall and separated mucosa in the
CC       distal ileum and colon. Expressed by enteroendocrine cells expressing
CC       peptide YY (PYY) (at protein level). {ECO:0000269|PubMed:16453106}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB106675; BAD02826.1; -; mRNA.
DR   RefSeq; NP_001005877.1; NM_001005877.1.
DR   RefSeq; XP_006228884.1; XM_006228822.3.
DR   RefSeq; XP_008757355.1; XM_008759133.2.
DR   RefSeq; XP_008757356.1; XM_008759134.2.
DR   RefSeq; XP_008757357.1; XM_008759135.1.
DR   RefSeq; XP_017444402.1; XM_017588913.1.
DR   AlphaFoldDB; Q76EI6; -.
DR   SMR; Q76EI6; -.
DR   STRING; 10116.ENSRNOP00000028532; -.
DR   BindingDB; Q76EI6; -.
DR   ChEMBL; CHEMBL3309100; -.
DR   GuidetoPHARMACOLOGY; 226; -.
DR   GlyCosmos; Q76EI6; 2 sites, No reported glycans.
DR   GlyGen; Q76EI6; 2 sites.
DR   PhosphoSitePlus; Q76EI6; -.
DR   PaxDb; 10116-ENSRNOP00000028532; -.
DR   Ensembl; ENSRNOT00000028532.3; ENSRNOP00000028532.1; ENSRNOG00000021021.3.
DR   Ensembl; ENSRNOT00000110584.1; ENSRNOP00000092741.1; ENSRNOG00000021021.3.
DR   Ensembl; ENSRNOT00000111135.1; ENSRNOP00000076649.1; ENSRNOG00000021021.3.
DR   Ensembl; ENSRNOT00055055984; ENSRNOP00055046140; ENSRNOG00055032419.
DR   Ensembl; ENSRNOT00055055988; ENSRNOP00055046144; ENSRNOG00055032419.
DR   Ensembl; ENSRNOT00060055345; ENSRNOP00060045789; ENSRNOG00060031916.
DR   Ensembl; ENSRNOT00060055348; ENSRNOP00060045792; ENSRNOG00060031916.
DR   Ensembl; ENSRNOT00065057411; ENSRNOP00065047252; ENSRNOG00065033395.
DR   Ensembl; ENSRNOT00065057412; ENSRNOP00065047253; ENSRNOG00065033395.
DR   GeneID; 292794; -.
DR   KEGG; rno:292794; -.
DR   UCSC; RGD:1359614; rat.
DR   AGR; RGD:1359614; -.
DR   CTD; 2867; -.
DR   RGD; 1359614; Ffar2.
DR   eggNOG; ENOG502QQGM; Eukaryota.
DR   GeneTree; ENSGT00990000203527; -.
DR   HOGENOM; CLU_009579_8_4_1; -.
DR   InParanoid; Q76EI6; -.
DR   OMA; EVCYENF; -.
DR   OrthoDB; 2899073at2759; -.
DR   PhylomeDB; Q76EI6; -.
DR   TreeFam; TF350010; -.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   Reactome; R-RNO-444209; Free fatty acid receptors.
DR   PRO; PR:Q76EI6; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000021021; Expressed in colon and 10 other cell types or tissues.
DR   GO; GO:0042995; C:cell projection; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IDA:UniProtKB.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0002752; P:cell surface pattern recognition receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0071398; P:cellular response to fatty acid; IDA:UniProtKB.
DR   GO; GO:0045444; P:fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0002232; P:leukocyte chemotaxis involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:1990806; P:ligand-gated ion channel signaling pathway; ISO:RGD.
DR   GO; GO:0019915; P:lipid storage; ISS:UniProtKB.
DR   GO; GO:0002385; P:mucosal immune response; ISS:UniProtKB.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0002879; P:positive regulation of acute inflammatory response to non-antigenic stimulus; ISS:UniProtKB.
DR   GO; GO:0032722; P:positive regulation of chemokine production; ISS:UniProtKB.
DR   GO; GO:0002720; P:positive regulation of cytokine production involved in immune response; ISS:UniProtKB.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; ISS:UniProtKB.
DR   GO; GO:0002673; P:regulation of acute inflammatory response; ISS:UniProtKB.
DR   GO; GO:0090276; P:regulation of peptide hormone secretion; ISS:UniProtKB.
DR   CDD; cd15170; 7tmA_FFAR2_FFAR3; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR013312; GPR40-rel_orph.
DR   PANTHER; PTHR45822:SF5; FREE FATTY ACID RECEPTOR 2; 1.
DR   PANTHER; PTHR45822; FREE FATTY ACID RECEPTOR 2-RELATED; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR01904; GPR40FAMILY.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; G-protein coupled receptor; Glycoprotein; Immunity;
KW   Inflammatory response; Lipid-binding; Membrane; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..330
FT                   /note="Free fatty acid receptor 2"
FT                   /id="PRO_0000228145"
FT   TOPO_DOM        1..8
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        9..29
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        30..43
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        44..64
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        65..79
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        80..100
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        101..126
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        127..147
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        148..184
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        185..205
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        206..219
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        220..240
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        241..255
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        256..276
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        277..330
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          300..330
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        312..330
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        151
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        167
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   330 AA;  36994 MW;  CF32C5B5D226670B CRC64;
     MTPDWHSSLI LTAYILIFLT GLPANLLALR AFVSRVRQPQ PAPVHILLLN LTLADLLLLL
     LLPFRIVEAA SNFRWYLPKI VCALTGFGFY SSIYCSTWLL AGISIERYLG VAFPVQYKLS
     RRPLYGVIAA LVAWIMSFGH CTIVIIVQYL NSTEQVGTEN QITCYENFTQ AQLDVVLPVR
     LELCLVLFFV PMTVTIFCYW RFVWIMLTQP HVGAQRRRRA VGLAVVTLLN FLVCFGPYNM
     SHLVGFHLRQ SPSWRVEAVV FSSLNASLDP LLFYFSSSVV RRAFGKGLLL LRNPGSSMLG
     RGAEETVEGT KTDRGGSQTE GAQSSDFVTE
//
